FCAP vs REGN · P/E 12, $211.2M cap vs P/E 14, rev $14.34B
First Capital Inc (FCAP) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
First Capital Inc (FCAP) is a banks - regional company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
FCAP does not have a complete income-statement cache yet.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FCAP currently screens at market cap $211.2M and trailing P/E 12.1. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FCAP and REGN stock pages for the full models.
Not investment advice.